CD8A and neoplasm: By encapsulating mRNA in lipid nanoparticles, the immunogenicity and antigen presentation efficiency of the mRNA vaccine is enhanced, enabling its effective targeted delivery to lymph nodes, activating CD8+ T cells, and thereby enhancing the immune system’s antigen-specific response to the tumor.